Cargando…

Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2–Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial

To investigate the efficacy and safety of trastuzumab deruxtecan, an antibody-drug conjugate targeting human epidermal growth factor receptor 2 (HER2) with a topoisomerase I inhibitor payload, in patients with uterine carcinosarcoma (UCS) expressing HER2. PATIENTS AND METHODS: Patients with recurren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishikawa, Tadaaki, Hasegawa, Kosei, Matsumoto, Koji, Mori, Masahiko, Hirashima, Yasuyuki, Takehara, Kazuhiro, Ariyoshi, Kazuya, Kato, Tomoyasu, Yagishita, Shigehiro, Hamada, Akinobu, Kawasaki, Mamiko, Kawashima, Satoshi, Tomatsuri, Sawako, Nagasaka, Yukari, Yoshida, Hiroshi, Machida, Ryunosuke, Hirakawa, Akihiro, Nakamura, Kenichi, Yonemori, Kan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2023
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414746/ https://www.ncbi.nlm.nih.gov/pubmed/36977309 http://dx.doi.org/10.1200/JCO.22.02558

Ejemplares similares

Symphoniae Sacrae II 1615/
por: Gabrieli Giovanni

Roll of the Indian Medical Service, 1615—1930
Publicado: (1931)

Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503)
por: Iwasa, Satoru, et al.
Publicado: (2020)

P1615: ASPECTS OF THE THERAPY SELECTION FOR IMMUNE THROMBOCYTOPENIA IN CHILDREN
por: Khoduleva, Sviatlana, et al.
Publicado: (2023)

Visualization of the distribution of nanoparticle-formulated AZD2811 in mouse tumor model using matrix-assisted laser desorption ionization mass spectrometry imaging
por: Ryu, Shoraku, et al.
Publicado: (2020)

Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study
por: Nishikawa, Tadaaki, et al.
Publicado: (2017)

Trastuzumab deruxtecan for breast cancer
Publicado: (2022)

One Electron Changes Everything: Synthesis, Characterization, and Reactivity Studies of [Re(NCCH(3))(6)](3+)
por: Bolliger, Robin, et al.
Publicado: (2022)

Deruxtecan-Induced Reversible Fanconi Syndrome
por: Kalantri, Pooja, et al.
Publicado: (2023)

Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma
por: Kojima, Yuki, et al.
Publicado: (2023)

Trends of uterine carcinosarcoma in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

1615. Influenza Outbreaks in Long-Term Care Facilities, 2017–2018 Influenza Season, Dallas, Texas
por: Chung, Wendy, et al.
Publicado: (2019)

Development of a Detection System for ESR1 Mutations in Circulating Tumour DNA Using PNA-LNA-Mediated PCR Clamping
por: Kojima, Yuki, et al.
Publicado: (2023)

A Phase I study of pevonedistat plus capecitabine plus oxaliplatin in patients with advanced gastric cancer refractory to platinum (NCCH-1811)
por: Shoji, Hirokazu, et al.
Publicado: (2021)

Population Pharmacokinetics of Patritumab Deruxtecan in Patients With Solid Tumors
por: Lu, Yasong, et al.
Publicado: (2022)

1615. Efficacy of Long-Acting Cabotegravir and Rilpivirine in a Diverse Group of Patients in a Real-World Setting
por: Yared, Nicholas F, et al.
Publicado: (2023)

Considerable increase in Poly(3-hydroxybutyrate) production via phbC gene overexpression in Ralstonia eutropha PTCC 1615
por: Barati, Farzaneh, et al.
Publicado: (2021)

Pulmonary carcinosarcoma showing an obvious response to pazopanib: a case report
por: Tanimoto, Azusa, et al.
Publicado: (2018)

Clinical utility of CA-125 in the management of uterine carcinosarcoma
por: Matsuo, Koji, et al.
Publicado: (2018)

Safety of trastuzumab deruxtecan: A meta‐analysis and pharmacovigilance study
por: Guo, Zihan, et al.
Publicado: (2022)

Carcinosarcoma of the ovary
por: Harris, M A, et al.
Publicado: (2003)

Carcinosarcoma in the Cecum
por: Ryu, Youngjoon, et al.
Publicado: (2012)

Carcinosarcoma of uterus
por: Tuan, Ho Xuan, et al.
Publicado: (2023)

EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. I. Collection of Virus Samples
por: Fout, G. Shay, et al.
Publicado: (2015)

1615P Impact of the COVID-19 pandemic on diagnosing and treatment referrals of lung cancer patients: A single-centre experience
por: Janzic, U., et al.
Publicado: (2021)

Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer
por: Kotani, Daisuke, et al.
Publicado: (2021)

Trastuzumab Deruxtecan: Changing the Destiny of HER2 Expressing Solid Tumors
por: Indini, Alice, et al.
Publicado: (2021)

Multifocal and pathologically-confirmed brain metastasis complete response to trastuzumab deruxtecan
por: Moss, Nelson S, et al.
Publicado: (2022)

Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
por: Rugo, H.S., et al.
Publicado: (2022)

Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases
por: Kabraji, Sheheryar, et al.
Publicado: (2023)

Primary carcinosarcoma of the gallbladder
por: Park, Sung Bae, et al.
Publicado: (2012)

Primary carcinosarcoma of the spleen
por: Joy, ER, et al.
Publicado: (2012)

Carcinosarcoma of the Maxillary Sinus
por: Moon, Jeong-Ki, et al.
Publicado: (2013)

Carcinosarcoma of the Thyroid Gland
por: Ekici, Mehmet Fatih, et al.
Publicado: (2015)

EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. II. Total Culturable Virus Assay
por: Fout, G. Shay, et al.
Publicado: (2016)

Primary Amine Nucleophilic Addition to Nitrilium Closo-Dodecaborate [B(12)H(11)NCCH(3)](−): A Simple and Effective Route to the New BNCT Drug Design
por: Nelyubin, Alexey V., et al.
Publicado: (2021)

Exploring Rhenium Arene Piano-Stool Chemistry with [Re(η(6)-C(6)H(6))(NCCH(3))(3)](+): A Powerful Semi-Solvated Precursor
por: Bolliger, Robin, et al.
Publicado: (2023)

Trastuzumab deruxtecan: An antibody-drug conjugate embracing its destiny in breast cancer
por: Makhlin, Igor, et al.
Publicado: (2022)

Trastuzumab deruxtecan in recurrent uterine serous carcinoma resistant to trastuzmab based-chemotherapy
por: McNamara, Blair, et al.
Publicado: (2023)

Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective
por: Henning, Jan-Willem, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_43aktsjjd4ab33kf1iu4etd10b